WS
EW icon

Wedbush Securities’s Edwards Lifesciences EW Stock Holding History

Wedbush Securities’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.09M Sell
13,559
-531
-4% -$43.8K 0.03% 423
2025
Q4 		$1.2M Sell
14,090
-1,992
-12% -$163K 0.04% 395
2025
Q3 		$1.25M Sell
16,082
-121
-0.7% -$9.45K 0.04% 358
2025
Q2 		$1.27M Sell
16,203
-731
-4% -$54.5K 0.04% 345
2025
Q1 		$1.23M Sell
16,934
-874
-5% -$62.6K 0.05% 332
2024
Q4 		$1.32M Sell
17,808
-449
-2% -$31.4K 0.05% 299
2024
Q3 		$1.21M Sell
18,257
-632
-3% -$45.9K 0.04% 320
2024
Q2 		$1.75M Buy
18,889
+285
+2% +$25.2K 0.06% 227
2024
Q1 		$1.78M Sell
18,604
-615
-3% -$51.7K 0.07% 234
2023
Q4 		$1.47M Sell
19,219
-370
-2% -$25.7K 0.06% 230
2023
Q3 		$1.36M Sell
19,589
-1,023
-5% -$82.2K 0.07% 227
2023
Q2 		$1.94M Sell
20,612
-3,235
-14% -$281K 0.09% 160
2023
Q1 		$1.97M Sell
23,847
-2,930
-11% -$230K 0.1% 159
2022
Q4 		$2M Sell
26,777
-2,511
-9% -$194K 0.11% 144
2022
Q3 		$2.42M Buy
29,288
+829
+3% +$79.8K 0.14% 118
2022
Q2 		$2.71M Sell
28,459
-1,174
-4% -$122K 0.15% 111
2022
Q1 		$3.49M Buy
29,633
+447
+2% +$50.1K 0.16% 102
2021
Q4 		$3.78M Buy
29,186
+6,173
+27% +$720K 0.16% 97
2021
Q3 		$2.6M Buy
23,013
+518
+2% +$59.1K 0.12% 130
2021
Q2 		$2.33M Buy
22,495
+5,124
+29% +$483K 0.11% 156
2021
Q1 		$1.45M Buy
17,371
+2,056
+13% +$174K 0.08% 232
2020
Q4 		$1.4M Sell
15,315
-2,168
-12% -$180K 0.12% 181
2020
Q3 		$1.4M Buy
17,483
+97
+0.6% +$7.57K 0.13% 161
2020
Q2 		$1.2M Buy
17,386
+925
+6% +$65.7K 0.11% 184
2020
Q1 		$1.03M Buy
16,461
+1,452
+10% +$105K 0.12% 169
2019
Q4 		$1.17M Buy
15,009
+939
+7% +$73.3K 0.1% 211
2019
Q3 		$1.03M Sell
14,070
-75
-0.5% -$5.27K 0.1% 230
2019
Q2 		$871K Sell
14,145
-480
-3% -$29K 0.09% 260
2019
Q1 		$933K Buy
14,625
+1,215
+9% +$69.3K 0.1% 234
2018
Q4 		$685K Buy
13,410
+4,380
+49% +$222K 0.09% 265
2018
Q3 		$524K Buy
9,030
+72
+0.8% +$3.52K 0.06% 377
2018
Q2 		$435K Sell
8,958
-3,972
-31% -$185K 0.05% 420
2018
Q1 		$601K Sell
12,930
-10,341
-44% -$449K 0.08% 306
2017
Q4 		$874K Buy
23,271
+810
+4% +$29.7K 0.11% 230
2017
Q3 		$818K Sell
22,461
-2,238
-9% -$85.4K 0.11% 221
2017
Q2 		$973K Buy
24,699
+1,200
+5% +$43.8K 0.13% 197
2017
Q1 		$737K Sell
23,499
-7,062
-23% -$221K 0.1% 244
2016
Q4 		$955K Buy
30,561
+25,020
+452% +$811K 0.14% 170
2016
Q3 		$223K Buy
+5,541
New +$209K 0.03% 626

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Wedbush Securities's EW Position: Q1 2026 in Review

Wedbush Securities reduced its Edwards Lifesciences (EW) stake by 3.8% in Q1 2026, selling an estimated $43.8K and leaving 13,559 shares worth $1.09M. The position accounts for 0.03% of the portfolio, ranked #423.

Wedbush Securities first reported a position in EW in Q3 2016 and has held it in 39 quarters since. The position peaked at $3.78M in Q4 2021. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Wedbush Securities held 13,559 shares of Edwards Lifesciences worth $1.09M as of Q1 2026.
  • Wedbush Securities sold 531 Edwards Lifesciences shares in Q1 2026, an estimated $43.8K.
  • Edwards Lifesciences made up 0.03% of Wedbush Securities's portfolio in Q1 2026, its #423 holding.
  • Wedbush Securities first reported a position in Edwards Lifesciences in Q3 2016 and has held it in 39 quarters since.
  • Wedbush Securities's Edwards Lifesciences position peaked at $3.78M in Q4 2021.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Wedbush Securities's 13F filing for Q1 2026, filed 21 Apr 2026.